Replies to post #132958 on Biotech Values

[oc631]

The adeno virus is long thought to be a better vector for gene therapy.

It appears this applies to cancer treatment as well. I'm anxious to see the phase 3 results for AMGN's OncoVex in melanoma. Any opinions on OncoVex?